At the time of writing, Transmedics Group Inc [TMDX] stock is trading at $91.82, down -2.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TMDX shares have gain 7.97% over the last week, with a monthly amount glided 11.49%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Transmedics Group Inc [NASDAQ: TMDX] stock has seen the most recent analyst activity on March 28, 2024, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $95. On August 02, 2022, upgrade upgraded it’s rating to Overweight but maintained its price target of $48 on the stock. JP Morgan downgraded its rating to a Neutral but stick to its price target of $15 on October 08, 2020. Oppenheimer initiated its recommendation with a Outperform and recommended $25 as its price target on April 07, 2020. In a note dated May 28, 2019, JP Morgan initiated an Overweight rating.
For the past year, the stock price of Transmedics Group Inc fluctuated between $36.42 and $99.63. Currently, Wall Street analysts expect the stock to reach $51 within the next 12 months. Transmedics Group Inc [NASDAQ: TMDX] shares were valued at $91.82 at the most recent close of the market. An investor can expect a potential drop of -44.46% based on the average TMDX price forecast.
Analyzing the TMDX fundamentals
According to Transmedics Group Inc [NASDAQ:TMDX], the company’s sales were 241.62M for trailing twelve months, which represents an 158.72% jump. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.1%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.17 and Total Capital is -0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 90.36 points at the first support level, and at 88.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.68, and for the 2nd resistance point, it is at 95.53.
Ratios To Look Out For
It is important to note that Transmedics Group Inc [NASDAQ:TMDX] has a current ratio of 9.30. Further, the Quick Ratio stands at 8.49, while the Cash Ratio is 7.19. Considering the valuation of this stock, the price to sales ratio is 12.43, the price to book ratio is 21.86.
Transactions by insiders
Recent insider trading involved Hassanein Waleed H, President & CEO, that happened on Apr 10 ’24 when 12000.0 shares were sold. Chief Commercial Officer, Khayal Tamer I completed a deal on Apr 09 ’24 to sell 15512.0 shares. Meanwhile, Chief Commercial Officer Khayal Tamer I sold 4388.0 shares on Apr 08 ’24.
